Tuulia M. Ortner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tuulia M. Ortner has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Eva Rohde
Department of Transfusion Medicine, University Hospital of Salzburg (SALK), Paracelsus Medical University (PMU) Salzburg, Müllner-Hauptstraße 48, 5020 Salzburg, Austria
3 shared publications Eva Weißkopf
Free University, Berlin, Germany
3 shared publicationsIsabella Vormittag
3 shared publications- Isabella Vormittag3 shared publications
- Sandra Laner-Plamberger
Department for Transfusion Medicine University Hospital of Salzburg (SALK), Paracelsus Medical University (PMU) Salzburg Salzburg Austria
3 shared publications - Sonja Breuer
Division of Psychological Assessment, Department of Psychology, Paris Lodron University, Salzburg, Austria
3 shared publications
Latest Publications
- Open Access
- 8 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (2) , 195
Reinfection-Driven Accumulation of SARS-CoV-2 Antibodies: A 36-Month Longitudinal Study in Austrian Blood Donors
Background/Objectives: Long-term serological studies are essential to understand how repeated antigenic exposure affects the specific humoral immune response. The aim of this study was to investigate the long-term SARS-CoV-2 antibody dynamics in Austrian blood donors, as representatives of healthy adults, over a period of 36 months after the first SARS-CoV-2 infection. Methods: SARS-CoV-2 anti-N antibody levels were determined in more than 146,000 blood donations collected between 2020 and 2025. In addition, SARS-CoV-2 anti-N and anti-S antibody dynamics were examined in 204 individual blood donors at predefined points in time over a period of 36 months. Reinfections were inferred from increases in anti-N levels within an individual. Vaccination history and self-reported infection data were documented. Results: Anti-N seroprevalence was over 90% from the beginning of 2023 and remained at this level until 2025. Among the longitudinally observed participants, 97% had at least one serologically detected reinfection and 50% had two or more. While anti-N levels continued to increase over time, suggesting cumulative antigenic stimulation, anti-S concentrations and in vitro antibody functionality remained consistently high. Self-reported reinfections underestimated the actual incidence by a factor of six. Symptom profiles shifted toward mild respiratory manifestations, with significantly fewer cases of hyposmia or dysgeusia reported compared to the initial infection. Conclusions: After three years of observation, SARS-CoV-2 immunity is characterized by sustained antibody activity. The results show a transition from persistent, but inherently declining, to a repeatedly rebuilding, enhanced humoral immunity, indicating that SARS-CoV-2 has become endemic in Austria.
- 8 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (2) , 195
Open AccessReinfection-Driven Accumulation of SARS-CoV-2 Antibodies: A 36-Month Longitudinal Study in Austrian Blood Donors
Background/Objectives: Long-term serological studies are essential to understand how repeated antigenic exposure affects the specific humoral immune response. The aim of this study was to investigate the long-term SARS-CoV-2 antibody dynamics in Austrian blood donors, as representatives of healthy adults, over a period of 36 months after the first SARS-CoV-2 infection. Methods: SARS-CoV-2 anti-N antibody levels were determined in more than 146,000 blood donations collected between 2020 and 2025. In addition, SARS-CoV-2 anti-N and anti-S antibody dynamics were examined in 204 individual blood donors at predefined points in time over a period of 36 months. Reinfections were inferred from increases in anti-N levels within an individual. Vaccination history and self-reported infection data were documented. Results: Anti-N seroprevalence was over 90% from the beginning of 2023 and remained at this level until 2025. Among the longitudinally observed participants, 97% had at least one serologically detected reinfection and 50% had two or more. While anti-N levels continued to increase over time, suggesting cumulative antigenic stimulation, anti-S concentrations and in vitro antibody functionality remained consistently high. Self-reported reinfections underestimated the actual incidence by a factor of six. Symptom profiles shifted toward mild respiratory manifestations, with significantly fewer cases of hyposmia or dysgeusia reported compared to the initial infection. Conclusions: After three years of observation, SARS-CoV-2 immunity is characterized by sustained antibody activity. The results show a transition from persistent, but inherently declining, to a repeatedly rebuilding, enhanced humoral immunity, indicating that SARS-CoV-2 has become endemic in Austria.
- 5 February 2025
- Published by Springer Nature
- p. 697-708
Eignungsdiagnostische Interviews
- 5 February 2025
- Published by Springer Nature
- p. 813-819
Objektive Persönlichkeitstests
- Open Access
- 13 June 2024
- Published by Taylor & Francis in Infectious Diseases
- Vol. 56 (11) , 954-964
Dissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infection
BackgroundUnderstanding the dynamics of SARS-CoV-2 reinfections is crucial for public health policy, vaccine development, and long-term disease management. However, data on reinfections in the general population remains scarce.ObjectivesThis study aimed to investigate SARS-CoV-2 antibody dynamics among Austrian blood donors, representing healthy adults, over two years following primary infection and to evaluate the reinfection risk.Methods117,895 blood donations were analysed for SARS-CoV-2 total anti-N levels from June 2020 to December 2023. We examined anti-N and anti-S antibody dynamics and in vitro functionality in 230 study participants at five defined times during 24 months, assessing associations with demographics, vaccination status, and reinfection awareness.ResultsThe seroprevalence of SARS-CoV-2 infection-derived anti-N antibodies increased over time, reaching 90% by February 2023 and remaining at that level since then. According to serological screenings, we found an 88% reinfection rate, which is in contrast to participants' reports indicating a reinfection rate of 59%. Our data further reveal that about 26% of reinfections went completely unnoticed. Antibody dynamics were independent of age, sex, and ABO blood group. Interestingly, individuals with multiple reinfections reported symptoms more frequently during their primary infection. Our results further show that vaccination modestly affected reinfection risk and disease course.ConclusionSARS-CoV-2 reinfections were uncommon until the end of 2021 but became common with the advent of Omicron. This study highlights the underestimation of reinfection rates in healthy adults and underscores the need for continued surveillance, which is an important support for public health policies and intervention strategies.
- 13 June 2024
- Published by Taylor & Francis in Infectious Diseases
- Vol. 56 (11) , 954-964
Open AccessDissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infection
BackgroundUnderstanding the dynamics of SARS-CoV-2 reinfections is crucial for public health policy, vaccine development, and long-term disease management. However, data on reinfections in the general population remains scarce.ObjectivesThis study aimed to investigate SARS-CoV-2 antibody dynamics among Austrian blood donors, representing healthy adults, over two years following primary infection and to evaluate the reinfection risk.Methods117,895 blood donations were analysed for SARS-CoV-2 total anti-N levels from June 2020 to December 2023. We examined anti-N and anti-S antibody dynamics and in vitro functionality in 230 study participants at five defined times during 24 months, assessing associations with demographics, vaccination status, and reinfection awareness.ResultsThe seroprevalence of SARS-CoV-2 infection-derived anti-N antibodies increased over time, reaching 90% by February 2023 and remaining at that level since then. According to serological screenings, we found an 88% reinfection rate, which is in contrast to participants' reports indicating a reinfection rate of 59%. Our data further reveal that about 26% of reinfections went completely unnoticed. Antibody dynamics were independent of age, sex, and ABO blood group. Interestingly, individuals with multiple reinfections reported symptoms more frequently during their primary infection. Our results further show that vaccination modestly affected reinfection risk and disease course.ConclusionSARS-CoV-2 reinfections were uncommon until the end of 2021 but became common with the advent of Omicron. This study highlights the underestimation of reinfection rates in healthy adults and underscores the need for continued surveillance, which is an important support for public health policies and intervention strategies.
- 8 March 2024
- Published by Springer Nature
- p. 1-7
Objektive Persönlichkeitstests
- Open Access
- 15 November 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-13
Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course
Purpose: Post-COVID-19-Syndrome (PCS) frequently occurs after an infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, the understanding of causative mechanisms is still limited. Aim of this study was to determine the PCS rate among SARS-CoV-2 seropositive blood donors as representatives of supposedly healthy adults, who had experienced an asymptomatic or mild COVID-19 disease course, and to examine whether Epstein-Barr virus (EBV) is reactivated in individuals reporting PCS. Methods: The PCS rate was determined using questionnaires that included questions about infection and persistent symptoms. Pre-pandemic blood samples and samples collected at regular, pre-defined times after a SARS-CoV-2 infection were analysed for neopterin, a marker for antiviral immune responses, by an enzyme-linked immunosorbent assay (ELISA). Additionally, we determined the rate of SARS-CoV-2 anti-N total antibodies using an electrochemiluminescence immunoassay (ECLIA). Furthermore, quantitative real-time polymerase chain reaction (qPCR) to detect EBV DNA and ECLIA screening for EBV viral capsid-antigen (VCA) IgM, IgG and EBV nuclear antigen 1 (EBNA) IgG were performed. Results: Our data reveal that 18% of all infections result in PCS, with symptoms lasting for up to one year. In individuals reporting PCS, no elevated levels of neopterin were detected, indicating no persisting pro-inflammatory, antiviral immune response. SARS-CoV-2 antibody levels were declining in all participants in comparable manner over time, pointing to a successful virus clearance. In individuals with PCS, no EBV DNA could be detected. Furthermore, no differences in EBV specific antibody levels could be shown in PCS groups compared to non-PCS groups. Conclusion: Our data suggest that PCS in per se healthy, immunocompetent adults cannot be ascribed to a reactivation of EBV.
- 15 November 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-13
Open AccessEpstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course
Purpose: Post-COVID-19-Syndrome (PCS) frequently occurs after an infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, the understanding of causative mechanisms is still limited. Aim of this study was to determine the PCS rate among SARS-CoV-2 seropositive blood donors as representatives of supposedly healthy adults, who had experienced an asymptomatic or mild COVID-19 disease course, and to examine whether Epstein-Barr virus (EBV) is reactivated in individuals reporting PCS. Methods: The PCS rate was determined using questionnaires that included questions about infection and persistent symptoms. Pre-pandemic blood samples and samples collected at regular, pre-defined times after a SARS-CoV-2 infection were analysed for neopterin, a marker for antiviral immune responses, by an enzyme-linked immunosorbent assay (ELISA). Additionally, we determined the rate of SARS-CoV-2 anti-N total antibodies using an electrochemiluminescence immunoassay (ECLIA). Furthermore, quantitative real-time polymerase chain reaction (qPCR) to detect EBV DNA and ECLIA screening for EBV viral capsid-antigen (VCA) IgM, IgG and EBV nuclear antigen 1 (EBNA) IgG were performed. Results: Our data reveal that 18% of all infections result in PCS, with symptoms lasting for up to one year. In individuals reporting PCS, no elevated levels of neopterin were detected, indicating no persisting pro-inflammatory, antiviral immune response. SARS-CoV-2 antibody levels were declining in all participants in comparable manner over time, pointing to a successful virus clearance. In individuals with PCS, no EBV DNA could be detected. Furthermore, no differences in EBV specific antibody levels could be shown in PCS groups compared to non-PCS groups. Conclusion: Our data suggest that PCS in per se healthy, immunocompetent adults cannot be ascribed to a reactivation of EBV.
- 1 July 2023
- Published by Hogrefe Publishing Group in Psychologische Rundschau
- Vol. 74 (3) , 182-184
Fachgruppe Differentielle Psychologie, Persönlichkeitspsychologie und psychologische Diagnostik
- 1 July 2023
- Published by Hogrefe Publishing Group in Psychologische Rundschau
- Vol. 74 (3) , 182-184
Fachgruppe Differentielle Psychologie, Persönlichkeitspsychologie und psychologische Diagnostik
- Open Access
- 3 May 2023
- Published by The Royal Society in Royal Society Open Science
- Vol. 10 (5) , 220456
Effects of response format on achievement and aptitude assessment results: multi-level random effects meta-analyses
Psychological achievement and aptitude tests are fundamental elements of the everyday school, academic and professional lives of students, instructors, job applicants, researchers and policymakers. In line with growing demands for fair psychological assessment tools, we aimed to identify psychometric features of tests, test situations and test-taker characteristics that may contribute to the emergence of test bias. Multi-level random effects meta-analyses were conducted to estimate mean effect sizes for differences and relations between scores from achievement or aptitude measures with open-ended (OE) versus closed-ended (CE) response formats. Results from 102 primary studies with 392 effect sizes revealed positive relations between CE and OE assessments (mean r = 0.67, 95% CI [0.57; 0.76]), with negative pooled effect sizes for the difference between the two response formats (mean d av = −0.65; 95% CI [−0.78; −0.53]). Significantly higher scores were obtained on CE exams. Stem-equivalency of items, low-stakes test situations, written short answer OE question types, studies conducted outside the United States and before the year 2000, and test-takers' achievement motivation and sex were at least partially associated with smaller differences and/or larger relations between scores from OE and CE formats. Limitations and the results’ implications for practitioners in achievement and aptitude testing are discussed.
- 3 May 2023
- Published by The Royal Society in Royal Society Open Science
- Vol. 10 (5) , 220456
Open AccessEffects of response format on achievement and aptitude assessment results: multi-level random effects meta-analyses
Psychological achievement and aptitude tests are fundamental elements of the everyday school, academic and professional lives of students, instructors, job applicants, researchers and policymakers. In line with growing demands for fair psychological assessment tools, we aimed to identify psychometric features of tests, test situations and test-taker characteristics that may contribute to the emergence of test bias. Multi-level random effects meta-analyses were conducted to estimate mean effect sizes for differences and relations between scores from achievement or aptitude measures with open-ended (OE) versus closed-ended (CE) response formats. Results from 102 primary studies with 392 effect sizes revealed positive relations between CE and OE assessments (mean r = 0.67, 95% CI [0.57; 0.76]), with negative pooled effect sizes for the difference between the two response formats (mean d av = −0.65; 95% CI [−0.78; −0.53]). Significantly higher scores were obtained on CE exams. Stem-equivalency of items, low-stakes test situations, written short answer OE question types, studies conducted outside the United States and before the year 2000, and test-takers' achievement motivation and sex were at least partially associated with smaller differences and/or larger relations between scores from OE and CE formats. Limitations and the results’ implications for practitioners in achievement and aptitude testing are discussed.
- 22 April 2022
- Published by Springer Nature
- p. 25-48
Ziele von Online-Self-Assessments: Die Bedeutung einer frühzeitigen Auftragsklärung
- 22 April 2022
- Published by Springer Nature
- p. 25-48
Ziele von Online-Self-Assessments: Die Bedeutung einer frühzeitigen Auftragsklärung
- 22 April 2022
- Published by Springer Nature
- p. 1-23
Ein Rahmenmodell zu Entwicklung, Wirkmechanismen und Bewertung von Online-Self-Assessments
- 22 April 2022
- Published by Springer Nature
- p. 1-23
Ein Rahmenmodell zu Entwicklung, Wirkmechanismen und Bewertung von Online-Self-Assessments